For fiscal 2026 (ended Jun 30, 2026), Immutep Limited reported A$24.17M of revenue and -A$79.30M of net income. Figures are in AUD, the currency of its SEC filings.
IMMP revenue was A$24.17M for fiscal 2026 (ended Jun 30, 2026), up 133.9% from fiscal 2025. Compound annual growth was +43.5% over 5 years and +28.1% over 10 years. It rose in 8 of the last 10 fiscal years. Fiscal 2026 is the highest of the 11 fiscal years on file.
IMMP net income was -A$79.30M for fiscal 2026 (ended Jun 30, 2026), compared with -A$61.43M in fiscal 2025.
IMMP diluted EPS was -A$0.05 for fiscal 2026 (ended Jun 30, 2026), compared with -A$0.04 in fiscal 2025.
IMMP free cash flow was -A$55.56M for fiscal 2026 (ended Jun 30, 2026), compared with -A$62.10M in fiscal 2025.
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | A$24.17M | A$10.33M | A$7.84M | A$5.20M | A$6.76M | A$3.97M | A$16.50M | A$7.49M | A$7.35M | A$4.22M |
| Research and development | A$76.66M | A$49.78M | A$31.47M | A$28.79M | A$25.34M | A$12.02M | A$15.57M | A$13.77M | A$9.99M | A$7.53M |
| Selling, general and admin | A$9.58M | A$8.64M | A$8.85M | A$8.68M | A$7.21M | A$6.28M | A$6.34M | A$6.37M | A$7.24M | A$4.35M |
| Interest expense | A$67.9K | A$37.1K | A$30.6K | A$20.4K | A$92.4K | A$9.8K | A$10.5K | A$0 | - | - |
| Pre-tax income | -A$79.30M | -A$61.43M | -A$42.72M | -A$39.90M | -A$32.21M | -A$29.90M | -A$13.47M | -A$18.34M | -A$12.74M | -A$10.10M |
| Income tax | A$0 | A$0 | A$0 | A$0 | A$34 | A$33 | A$37 | A$0 | A$1.7K | -A$737.4K |
| Net income | -A$79.30M | -A$61.43M | -A$42.72M | -A$39.90M | -A$32.21M | -A$29.90M | -A$13.47M | -A$18.34M | -A$12.75M | -A$9.37M |
| EPS, basic | -A$0.05 | -A$0.04 | -A$0.04 | -A$0.04 | -A$0.04 | -A$0.05 | -A$0.03 | -A$5.29 | -A$4.63 | -A$3.80 |
| EPS, diluted | -A$0.05 | -A$0.04 | -A$0.04 | -A$0.04 | -A$0.04 | -A$0.05 | -A$0.03 | -A$5.29 | -A$4.63 | -A$3.80 |
| Diluted shares | 1.47B | 1.46B | 1.20B | 892.4M | 849.0M | 594.9M | 412.9M | 346.8M | 275.1M | 249.5M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | A$63.67M | A$67.41M | A$161.79M | A$123.42M | A$80.00M | A$60.59M | A$26.32M | A$16.57M | A$23.48M | A$12.24M |
| Receivables | A$9.41M | A$9.87M | A$7.35M | A$7.95M | A$8.37M | A$6.12M | A$3.29M | A$5.19M | A$3.43M | A$2.19M |
| Current assets | A$80.63M | A$149.10M | A$191.35M | A$134.97M | A$90.81M | A$68.42M | A$31.15M | A$23.54M | A$28.64M | A$15.92M |
| Total assets | A$83.27M | A$156.98M | A$201.58M | A$147.45M | A$102.17M | A$82.03M | A$46.60M | A$40.54M | A$47.00M | A$34.96M |
| Current liabilities | A$14.16M | A$12.76M | A$10.49M | A$9.77M | A$6.41M | A$5.34M | A$3.36M | A$5.30M | A$3.85M | A$2.63M |
| Total liabilities | A$21.73M | A$13.35M | A$12.06M | A$10.98M | A$8.09M | A$8.76M | A$13.30M | A$16.15M | A$13.48M | A$8.43M |
| Shareholders' equity | A$61.53M | A$143.64M | A$189.52M | A$136.47M | A$94.08M | A$73.27M | A$33.30M | A$24.39M | A$33.52M | A$26.53M |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -A$55.46M | -A$62.05M | -A$34.82M | -A$35.36M | -A$30.23M | -A$17.64M | -A$10.84M | -A$15.29M | -A$7.78M | -A$8.51M |
| Capital expenditures | A$92.9K | A$45.8K | A$29.2K | A$82.7K | A$22.9K | A$15.6K | A$19.3K | A$41.4K | A$11.9K | A$6.6K |
| Free cash flow | -A$55.56M | -A$62.10M | -A$34.85M | -A$35.44M | -A$30.25M | -A$17.66M | -A$10.86M | -A$15.33M | -A$7.79M | -A$8.51M |
| Investing cash flow | A$56.46M | -A$38.53M | -A$21.02M | -A$82.7K | -A$22.9K | -A$15.6K | -A$19.3K | -A$41.4K | -A$11.9K | -A$6.6K |
| Financing cash flow | -A$214.4K | -A$525.1K | A$95.18M | A$76.02M | A$50.33M | A$52.68M | A$20.48M | A$8.01M | A$18.40M | -A$8.5K |
| Stock-based compensation | A$1.59M | A$1.16M | A$1.80M | A$2.00M | A$1.49M | A$1.70M | A$1.72M | A$1.58M | A$2.26M | A$862.2K |
| Line item | Jun 30, 2026 | Jun 30, 2025 | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 | Jun 30, 2019 | Jun 30, 2018 | Jun 30, 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth, YoY | 133.9% | 31.8% | 50.7% | -23.1% | 70.3% | -76.0% | 120.3% | 1.9% | 74.2% | 108.1% |
| Net margin | -328.1% | -594.6% | -545.0% | -767.2% | -476.6% | -753.6% | -81.6% | -244.9% | -173.3% | -221.9% |
| Free cash flow margin | -229.9% | -601.0% | -444.6% | -681.5% | -447.7% | -444.9% | -65.8% | -204.7% | -105.9% | -201.7% |
| Return on equity | -128.9% | -42.8% | -22.5% | -29.2% | -34.2% | -40.8% | -40.4% | -75.2% | -38.0% | -35.3% |
| Return on assets | -95.2% | -39.1% | -21.2% | -27.1% | -31.5% | -36.5% | -28.9% | -45.2% | -27.1% | -26.8% |
| Current ratio | 5.69 | 11.69 | 18.25 | 13.81 | 14.16 | 12.81 | 9.26 | 4.44 | 7.43 | 6.05 |
Source: XBRL data Immutep Limited files with the SEC, latest filing dated Oct 23, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.
Per-share figures and share counts are restated for stock splits the filings show: 2-for-19, first reported Sep 25, 2020.
EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.
Foreign private issuers file annual reports with the SEC, so there are no quarterly statements here.
| Company | Revenue | Growth | Net income | Net margin | Market cap |
|---|---|---|---|---|---|
| IMMP | A$24.17M | +133.9% | -A$79.30M | -328.1% | $28.0M |
| REGN | $16.90B | +18.6% | $4.82B | 28.5% | $95.17B |
| MRK | $67.38B | +4.9% | $2.45B | 3.6% | $366.73B |
| BMY | $50.03B | +4.2% | $9.24B | 18.5% | $127.01B |
| IOVA | $378.98M | +51.3% | -$220.53M | -58.2% | $3.78B |
| AGEN | $133.95M | +25.4% | $29.53M | 22.0% | $323.5M |